Carbon monoxide-induced TFEB nuclear translocation enhances mitophagy/mitochondrial biogenesis in hepatocytes and ameliorates inflammatory liver injury

Cell Death Dis. 2018 Oct 17;9(11):1060. doi: 10.1038/s41419-018-1112-x.

Abstract

Carbon monoxide (CO) can confer protection against cellular stress, whereas the potential involvement of autophagy and lysosomal biogenesis remains incompletely understood. We demonstrate here that the activation of protein kinase R (PKR)-like endoplasmic reticulum (ER) kinase (PERK) with CO increased the nuclear translocation of transcription factor EB (TFEB). PERK activation by CO increased intracellular Ca2+ concentration and the phosphatase activity of calcineurin against TFEB. Moreover, we found that in the deficiency of TFEB, CO not only failed to recruit Parkin to the mitochondria but also failed to increase expression of lysosomal genes such as Lamp1, CathB, and TPP1. Therefore, we suggest that CO increases mitophagy through TFEB nuclear translocation by PERK-calcinuerin activation. In addition, the inhibition of TFEB with siRNA against TFEB abrogated the increase of mtDNA with CO, markers of mitochondrial biogenesis such as PGC1α, NRF1, and TFAM, and the mitochondrial proteins COX II, COX IV, and cytochrome c. To investigate the effects of CO on mitochondrial homeostasis in vivo, mice were treated with lipopolysaccharide (LPS)/D-galactosamine (D-GalN). CO inhalation reduced liver injury after challenge with LPS/GalN. Furthermore, CO inhalation increased TFEB activation, mitophagy and mitochondrial biogenesis in mice treated with LPS/GalN. Our findings describe novel mechanisms underlying CO-dependent cytoprotection in hepatocytes and liver tissue via activation of TFEB-dependent mitophagy and associated induction of both lysosomal and mitochondrial biogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Active Transport, Cell Nucleus / drug effects*
  • Animals
  • Antimetabolites / pharmacology*
  • Autophagy / drug effects
  • Autophagy / genetics
  • Basic Helix-Loop-Helix Leucine Zipper Transcription Factors / genetics*
  • Basic Helix-Loop-Helix Leucine Zipper Transcription Factors / metabolism
  • Biomarkers / metabolism
  • Calcineurin / genetics
  • Calcineurin / metabolism
  • Carbon Monoxide / pharmacology*
  • Chemical and Drug Induced Liver Injury / genetics
  • Chemical and Drug Induced Liver Injury / metabolism
  • Chemical and Drug Induced Liver Injury / pathology
  • Chemical and Drug Induced Liver Injury / prevention & control*
  • Galactosamine / administration & dosage
  • Galactosamine / antagonists & inhibitors
  • Gene Expression Regulation
  • Hepatocytes / drug effects
  • Hepatocytes / metabolism
  • Hepatocytes / pathology
  • Inflammation
  • Lipopolysaccharides / administration & dosage
  • Lipopolysaccharides / antagonists & inhibitors
  • Liver / drug effects
  • Liver / metabolism
  • Liver / pathology
  • Lysosomes / drug effects
  • Lysosomes / metabolism
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mitochondria / drug effects
  • Mitochondria / metabolism
  • Mitophagy / drug effects
  • Mitophagy / genetics
  • Organelle Biogenesis
  • RNA, Small Interfering / genetics
  • RNA, Small Interfering / metabolism
  • Signal Transduction
  • Tripeptidyl-Peptidase 1
  • Ubiquitin-Protein Ligases / genetics
  • Ubiquitin-Protein Ligases / metabolism
  • eIF-2 Kinase / genetics
  • eIF-2 Kinase / metabolism

Substances

  • Antimetabolites
  • Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
  • Biomarkers
  • Lipopolysaccharides
  • RNA, Small Interfering
  • Tcfeb protein, mouse
  • Tpp1 protein, mouse
  • Tripeptidyl-Peptidase 1
  • Galactosamine
  • Carbon Monoxide
  • Ubiquitin-Protein Ligases
  • parkin protein
  • PERK kinase
  • eIF-2 Kinase
  • Calcineurin